107
Geographic Atrophy
33. Holz FG, Schutt F, Kopitz J, et al. Inhibition of Lysosomal
Degradative Functions in RPE Cells by a Retinoid Com-
ponent of Lipofuscin. Invest Ophthalmol Vis Sci. 1999;
40:737-743.
34. Beatty S, Koh H, Phil M, et al. The Role of Oxidative
Stress in the Pathogenesis of Age-Related Macular Degen-
eration. Surv Ophthalmol. 2000; 45:115-134.
35. Rózanowska
M,
Korytowski
W,
Rózanowski
B, et al. Photoreactivity of Aged Human RPE
Melanosomes: A Comparison with Lipofuscin.
Invest Ophthalmol Vis Sci. 2002; 43:2088-2096.
36. Anderson DH, Mullins RF, Hageman GS, et al. A Role
for Local Inflammation in the Formation of Drusen in the
Aging Eye. Am J Ophthalmol. 2002; 134:411-431.
37. Coleman H R, Ferris III FL, Chew EY, et al. Age related
macular degeneration. Lancet. 2008 ; 372 (9652):1835-
1845.
38. Bischoff P, Speiser P. The role of angiography in age-re-
lated macular degeneration . Klin Monatsbl Augenheilkd.
1997; 210:196-8. Abstract.
39. Shuman JS, Puliafito CA, Fujimoto JG, et al. Optical Co-
herence Tomography of Ocular Diseases. Second edition.
Slack, 2004.
40. Bearelly S, Chau FY, Koreishi A, et al. Spectral Domain
Coherence Tomography Imaging of Geographic Atrophy
Margins. Ophthalmology. 2009; 116:1762-1769.
41. Fleckenstein M, Issa PC, Holz FG, et al. High-Resolution
Spectral Domain-OCT Imaging in Geographic Atrophy
Associated with Age-Related Macular Degeneration. In-
vest Ophthalmol Vis Sci. 2008; 49(9):4137-4144.
42. Delori FC, Dorey CK, Staurenghi G, et al. In Vivo Fluo-
rescence of the Ocular Fundus Exhibits Retinal Pigment
Epithelium Lipofuscin Characteristics. Invest Ophthal-
mol Vis Sci 1995;36:718-729.
43. Sparrow JR, Fishkin N, Zhou J, et al. A2E, a Byoproduct
of the Visual Cycle. Vision Res. 2003; 43:2983-2990.
44. Frangieh GT, Green WR, Fine SL. A histopathological
Study of Best’s Macular Dystrophy. Arch Ophthalmol.
1982; 100: 1115-1121.
45. Sparrow JR, Boulton M. Lipofuscin and its role in retinal
pathobiology. Exp Eye Res. 2005; 80: 595-606.
46. Von Ruckmann A, Fitzke FW, Bird AC. Fundus Autoflu-
orescence in Age-Related Macular Disease Imaged with
Laser scanning Ophthalmoscope. Invest Ophthalmol Vis
Sci. 1997; 38:478-86.
47. Holz FG, Bellman C, Staudt S, et al. Fundus Autofluores-
cence and Development of Geographic Atrophy in Age-
Related Macular Degeneration. Invest Ophthalmol Vis
Sci. 2001; 42:1051-1056.
48. Schmitz-Valkenberg S, Bültmann S, Dreyhaupy J, et al.
Fundus autofluorescence and fundus perimetry in the
junctional zone of geographic atrophy in patients with
age-related macular degeneration. Invest Ophthalmol Vis
Sci. 2004; 45:4470-4476.
49. Schmitz-Valckenberg S, Bindewald-Wittich A, Dolar-Szc-
zasny J, et al. Fundus Autofluorescence and Fundus Per-
imetry in the Junctional Zone of Geographic Atrophy in
Patients with Age-Related Macular Degeneration. Invest
Ophthalmol Vis Sci. 2006; 47:2648-2654.
50. Hwang JC, Chan JWK, Smith T, et al. Predictive Value of
Fundus Autofluorescence for Development of Geographic
Atrophy in Age-Related Macular Degeneration. Invest
Ophthalmol Vis Sci. 2006;47: 2655-2661.
51. Suness JS, Gonzalez-Baron J, Bressler NM, et al. The De-
velopment of Choroidal Neovascularization in Eyes with
Geographic Atrophy Form of Age-Related Macular De-
generation. Ophthalmology.1999; 106:910-919.
52. Suness JS, Applegate CA, Bressler NM, et al. Visual Func-
tion Abnormalities and Prognosis in Eyes with Age-Relat-
ed Geographic Atrophy of the Macula and Good Visual
Acuity. Ophthalmology.1997; 1677-1691.
53. Suness JS, Margalit E, Bressler NM, et al. The Long-term
Natural History of Geographic Atrophy from Age-Related
Macular Degeneration: Enlargement of Atrophy and Im-
plications for Interventional Clinical Trials. Ophthalmol-
ogy. 2007;114:271-277.
54. Bellmann C, Jorzik J, Spital G, et al. Symmetry of bilateral
lesions in geographic atrophy in patients with age-related
macular degeneration. Ophthalmology. 2002; 120: 579-
584.
55. Suness JS, Rubin GS, Broman A, et al. Low luminance
Visual Dysfunction as a Predictor of Subsequent Visual
Loss From Geographic Atrophy in Age-Related Macular
Degeneration. Ophthalmology. 2008; 115:1480-1488
56. Maguire P, Vine AK. Geographic Atrophy of Retinal Pig-
ment Epithelium. Am J Ophthalmol.1986; 102: 621-625.
57. Suness JS, Gonzalez-Baron J, Applegate CA, et al. En-
largement of Atrophy and Visual Acuity Loss in the Geo-
graphic Atrophy Form of Age-Related Macular Degenera-
tion. Ophthalmology. 1999; 106:1768-1779.
58. Schatz H, McDonald HR. Atrophic Macular Degenera-
tion. Rate of Spread of Geographic Atrophy and Visual
Loss. Ophthalmology. 1989; 96: 1541-1551.
59. Coleman H, Chew E. Nutritional Supplementation in
Age-Related Macular Degeneration. Curr Opin Ophthal-
mol. 2007; 18: 220-223.
60. Age-Related Eye Disease Study Research Group. Risk Fac-
tors for the Incidence of Advanced Age-Related Macular
Degeneration in Age-Related Eye Disease Study : AREDS
report nº 23. Arch Ophthalmol.2008; 126: 1274-1279.
61. Chiu CJ, Milton RC, Klein R et al. Dietary Compound
Score and Risk of Age-Related Macular Degeneration
in the Age-Related Eye Disease Study. Ophthalmol-
ogy.2008;116: 939-946.
62. Rosenfeld PJ, Legarreta J. Preclinical/ Phase I Dry AMD
Rx Pipeline Review. AAO Subspeciality Day Retina Sil-
labus.2009; p80-84.
63. Tao W, Wen R, Goddard MB, et al. Encapsulated Cell-
based Delivery of CNTF Reduces Photoreceptor Degen-
eration in Animal Models of Retinitis Pigmentosa. Invest
Ophthalmol Vis Sci. 2002; 43:3292-3298.
64. Konstantin Petrukin. New Therapeutic Targets in Atroph-
ic Age-Related Macular Degeneration. Expert Opin Ther
Targets. 2007; 11: 625-639.
65. Tanito M, Li F, Elliot MH, et al. Protective effect of TEM-
POL derivates against Light-Induced Retinal Damage in
Rats. Invest Ophthalmol Vis Sci. 2007; 48:1900-1905.
66. Zhou J, Kim SR, Sparrow JR, et al. Complement Activa-
tion by Bisretinoid Constituents of RPE Lipofuscin. In-
vest Ophthalmol Vis Sci. 2009; 50:1392-1399.
